Medical cannabis has emerged as a potential therapeutic option in the treatment of Alzheimer’s disease, a neurodegenerative disorder characterized by cognitive decline and memory loss. The disease process involves the accumulation of beta-amyloid plaques and tau tangles, leading to neuroinflammation and neuronal damage. Recent medical journal articles provide insights into the potential benefits of medicinal marijuana for Alzheimer’s disease. 

For instance, a study published in 2021 [1] demonstrated the neuroprotective effects of cannabinoids, such as THC and CBD, in reducing neuroinflammation and oxidative stress associated with Alzheimer’s pathology. 

Another study from 2020 [2] highlighted the potential of certain cannabinoids in improving memory performance and cognitive function. Moreover, research suggests that medical cannabis may help manage behavioral symptoms, including aggression and anxiety [3]. 

While further research is needed, these studies contribute to the growing evidence supporting the potential of medical cannabis as an adjunctive treatment for Alzheimer’s disease.Medical marijuana won’t cure the symptoms of Alzheimer’s, but can help to reduce the effects of negative symptoms. 

If you or someone you know are considering getting your medical cannabis card, consult your physician first.